FDA Approves COVID-19 Treatment

MEXICO-HEALTH-VIRUS

On Sunday, the FDA issued an emergency authorization for convalescent plasma to treat COVID-19.

They said the risks way less this way, the "known and potential benefits of the product outweigh the known and potential risks of the product."

Over 70,000 people have seen results with this treatment, according to the FDA.

"Convalescent plasma" uses the blood of people who have recovered from coronavirus infections.


Sponsored Content

Sponsored Content